News Articles and Montana BioScience Alliance Newsletters

MONTANA BIOSCIENCE ENTERPRISES IN THE NEWS

Montana BioScience Alliance
|
December 12, 2024

In recognition of her extraordinary contributions, Sharon has been inducted into the Montana Bioscience Hall of Fame, a fitting tribute to her enduring impact on our bioscience community. And to further honor her legacy, we are proud to announce the creation of the Sharon Peterson STEM Scholarship.

Gaize
|
September 5, 2024

Device developed by Missoula company Gaize (gaize.ai) could help to keep people safe at work and on the road.

C2M Beta
|
August 19, 2024

2M Beta is a 12-week program delivering the foundational and modern skills required to transform influential ideas into thriving businesses. With access to more professional expertise, more state-of-the-art technology and more community resources, C2M Beta was founded with the mission to connect local entrepreneurs to more!

Montana BioScience Alliance
|
July 25, 2024

A message from Board President Cynthia Tsai

SPI Pharma, Inc. a global leader in biopharmaceutical excipient and adjuvant systems, and Inimmune, Corp., a pioneering biotechnology company specializing in the discovery and development of innate immune modulators, announce an agreement in principle to create a strategic collaboration to develop and commercialize advanced adjuvant systems for vaccine development. This collaboration leverages Inimmune’s world-class expertise in adjuvant formulation and immunotherapeutics and SPI Pharma’s extensive manufacturing and global commercial capabilities.

ARTICLES OF INTEREST

Congress has returned to Capitol Hill, and among the most important unfinished business on its agenda is agreeing to a new package to fight COVID-19 by funding second-generation vaccine research. When Congress left town, there was cautious optimism that a deal was close.

Rocky Mountain Life Sciences Investor and Partnering Conference
|
April 7, 2022

Thirty regional companies will be selected to present at the Rocky Mountain Life Sciences Investor & Partnering Conference. Companies seeking seed, early-stage, late-stage funding in the medical device, diagnostic, biotech, pharmaceutical, and digital health sectors are encouraged to apply.

Biotechnology Innovation Organization (BIO)
|
February 25, 2022

With new labeling requirements, bioengineering entered consumer consciousness in a new way this year—but people are learning the benefits, according to Sarah Gallo, BIO’s VP of Agriculture and Environment, in this podcast.

Nine Questions for the World
|
January 4, 2022

From the NIne Questions for the World podcast, December 15, 2021. BIO President Michelle McMurray-Heath is interviewed by Richard Haass.

NEWSLETTER

Newsletter
|
December 12, 2024

View the December BIOWire Newsletter now!

Newsletter
|
August 26, 2024

View the September 2024 Newsletter now!